RMD

Resmed
NYSE

Real-time Quotes | Nasdaq Last Sale

160.82
+2.00
+1.26%
Closed 17:26 05/29 EDT
OPEN
161.00
PREV CLOSE
158.82
HIGH
161.60
LOW
157.09
VOLUME
943.48K
TURNOVER
--
52 WEEK HIGH
177.99
52 WEEK LOW
108.85
MARKET CAP
23.27B
P/E (TTM)
45.42
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 9 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average RMD stock price target is 166.80 with a high estimate of 200.00 and a low estimate of 135.00.

EPS

RMD News

More
The Retiree's Dividend Portfolio - Jane's April Update: Looking More Like A Return To Normalcy
Seeking Alpha - Article · 16h ago
ResMed (RMD) Up 3.5% Since Last Earnings Report: Can It Continue?
ResMed (RMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 1d ago
Rugby League Legend Brad Fittler Teams Up with ResMed to Help Australians Sleep Better
ResMed and Rugby League Hall of Famer and head coach Brad Fittler are teaming up to raise Australians' awareness of the importance of healthy sleep.
Business Wire · 4d ago
Wednesday Morning Market Highlights
GuruFocus.com · 4d ago
ResMed's Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort Inhaler to its Digital Health Platform
Benzinga · 5d ago
Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort® Inhaler to its Digital Health Platform
Propeller Health's digital sensor and app for AstraZeneca's Symbicort inhaler has received 510(k) clearance from the U.S. FDA.
Business Wire · 5d ago
Top Health Care Stocks for June 2020
Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and h
Investopedia · 05/21 18:49
MatrixCare Celebrates Post-acute Healthcare Workers with National Heroes Program
Over 140 long-term care facility and home-based care employees recognized for commitment to patient and resident safety during the COVID-19 pandemic.
Business Wire · 05/20 13:00

Industry

Advanced Medical Equipment & Technology
+1.42%
Healthcare Equipment & Supplies
+1.33%

Hot Stocks

Symbol
Price
%Change

About RMD

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
More

Webull offers kinds of ResMed Inc. stock information, including NYSE:RMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMD stock news, and many more online research tools to help you make informed decisions.